![J.J. Kiladjian: First European Use of Anti-Mutant CALR Bispecific Antibody for Myelofibrosis](https://oncodaily.com/pub/uploads/2024/08/jjkildjian-e1724415626703.jpg)
Photo of J.J. Kiladjian from vjhemonc.com
Aug 23, 2024, 14:01
J.J. Kiladjian: First European Use of Anti-Mutant CALR Bispecific Antibody for Myelofibrosis
J.J. Kiladjian, Professor of Clinical Pharmacology at Paris Diderot University, shared on X:
“Today at CIC Saint-Louis, a patient with myelofibrosis started for the 1st time in Europe a treatment with an anti-mutant CALR bispecific antibody.”
Source: J.J. Kiladjian/X